Subscribe: NewswireToday - Free Press Release - Free Newswire Distribution - Pharma/BioTech/Nutrition
http://www.newswiretoday.com/xml/17/
Preview: NewswireToday - Free Press Release - Free Newswire Distribution - Pharma/BioTech/Nutrition

NewswireToday - Free Press Release - Free Newswire Distribution - Pharma/BioTech/Nutrition



Recent Pharma/BioTech/Nutrition NewswireToday - PRZOOM Headline News - Visit PressReleasesNewswireDistribution.com



Published: Mon, 23 Jan 2017 17:00:22 -0500

 



PleurX™ Catheter System Receives FDA 510(k) Clearance for Specific Non-Malignant Recurrent Pleural Effusions

2017/01/23

NewswireToday (newswire) - 2017/01/23 Franklin Lakes, NJ United States - Indication for Congestive Heart Failure on Display at the 2017 Society of Thoracic Surgeons (STS) Meeting - BD.com



First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System

2017/01/10

NewswireToday (newswire) - 2017/01/10 Farnham, Surrey United Kingdom - BTG plc, the global specialist healthcare company, today announced the first patients diagnosed with Pulmonary Embolism (PE) to be treated in Hong Kong using the newly available EKOS® system - BTGplc.com



Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals

2017/01/09

NewswireToday (newswire) - 2017/01/09 Paris, Ile-de-France France - Ipsen will gain exclusive commercialization rights for the current and potential future ONIVYDE indications in the US - IPSEN.ca



FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer

2017/01/08

NewswireToday (newswire) - 2017/01/08 South San Francisco, CA United States - Genentech has accepted the company’s supplemental Biologics License Application (sBLA) and granted Priority Review for TECENTRIQ® (atezolizumab) for the treatment of people with locally advanced or metastatic urothelial carcinoma (mUC) - TECENTRIQ.com



FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization

2017/01/06

NewswireToday (newswire) - 2017/01/06 South San Francisco, CA United States - This approval is based on the results of the Phase III RADIANCE study, which demonstrated that treatment with Lucentis provided superior visual acuity gains in people with mCNV compared to verteporfin photodynamic therapy (vPDT) - Gene.com



Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN

2016/12/27

NewswireToday (newswire) - 2016/12/27 Saitama, Japan - RIKEN-Max Planck Joint Research Center for Systems Chemical Biology and a number of other institutes have identified a sugar molecule that reduced the inflammatory response and progress of emphysema - Riken.jp



Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada

2016/12/21

NewswireToday (newswire) - 2016/12/21 Paris, Ile-de-France France - Exelixis, Inc. and Ipsen jointly announced an amendment to the exclusive collaboration and licensing agreement for the commercialization and continued development of cabozantinib [NASDAQ: EXEL] - Exelixis.com / IPSEN.com



FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)

2016/12/20

NewswireToday (newswire) - 2016/12/20 South San Francisco, CA United States - Genentech announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) date for its review of the Biologics License Application (BLA) of OCREVUS™ (ocrelizumab) to March 28, 2017 - Gene.com



MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China

2016/12/19

NewswireToday (newswire) - 2016/12/19 Irvine, CA United States - MDxHealth SA announced that it has signed a distribution agreement with AceCGT Life Science Limited for their SelectMDx™ for Prostate Cancer assay in Hong Kong and Macao, Special Administrative Regions of the People's Republic of China



Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems

2016/12/16

NewswireToday (newswire) - 2016/12/16 London, United Kingdom - Puse are awarded highest level accreditation partnership with Veeva Systems - WeArePulse.co.uk



BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics

2016/12/15

NewswireToday (newswire) - 2016/12/15 Franklin Lakes, NJ United States - New BD Neopak™ 2.25 mL Prefillable Glass Syringe Helps Improve Safety and Convenience for Patients - BD.com



Sartorius Announces Expansion of Sartorius Stedim Cellca

2016/12/14

NewswireToday (newswire) - 2016/12/14 Göttingen, Germany - Sartorius Stedim Cellca based near Ulm in southern Germany, continues on the growth track - Sartorius-Stedim.com



Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch

2016/12/07

NewswireToday (newswire) - 2016/12/07 London, United Kingdom - With their enhanced drug absorption and drug stability, Nemaura’s easy-to-use transdermal technologies are expected to improve patient compliance and outcomes - Nemaura.co.uk / Frost.com



Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting

2016/12/06

NewswireToday (newswire) - 2016/12/06 King of Prussia, PA United States - Executive to Present Session: “Evaluate the Importance of Financial Transparency to Maximize Stakeholder Collaboration” - CBInet.com / Greenphire.com



BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management

2016/12/05

NewswireToday (newswire) - 2016/12/05 Las Vegas, NV United States - Experience the Difference of Enterprise-wide Medication Management at #ASHP16 Midyear Meeting - BD.com